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Impaired presentation of self-derived antigens in ABL but not FHBL. Monocyte-derived DCs from healthy controls and ABL patients (A and B) 
or FHBL patients (C) were cultured at the indicated concentrations with 5 × 104 CD1a-, CD1b-, and CD1c-restricted T cells or CD1d-restricted 
iNKT cells. Cytokine release of T cells was determined after 18–20 hours of coculture by ELISA. Culture of DCs or T cells alone did not lead to 
detectable cytokine production. CD1 restriction is demonstrated by blocking of the T cell response by anti-CD1 antibodies (B). One representa-
tive experiment is shown. Two additional experiments with cells from independent ABL, FHBL and control subjects gave comparable results.
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Impaired presentation of exogenous antigens in ABL. DCs (A and D–H), monocytes (B) or B cells (C) (2 × 104) were cocultured with 1 × 105 CD1d-
restricted NKT cells (A–D and H) or CD1b- (E) or CD1c-restricted T cells (F) in the presence of αGalCer (A–C, 100 ng/ml in C), GMM (E), man-
nosyl-phosphomycoketide (MPM; F), BbGL-IIf (10 μg/ml, D), or GSL-1 (10 μg/ml, D). In G, DCs were cocultured with CD1c-restricted T cells at the 
indicated days after infection with M. tuberculosis H37Rv. In H, DCs were cocultured with CD1d-restricted iNKT cells in the presence of the indicated 
heat-killed bacteria (MOI of 20). In some cases, blocking antibodies against CD1d or IL-12 were added. Cytokine release of T cells was determined 
after 18–20 hours of coculture by ELISA. Culture of DCs or T cells alone did not lead to detectable cytokine production. One representative experi-
ment is shown. Two additional experiments with cells from independent ABL and control subjects showed comparable results. bac, bacteria.
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Unaltered MHC class I– and class II–restricted antigen presentation 
in ABL patients. (A) PBMCs (2 ×105) were cultured in the presence 
or absence of 2 μg/ml CEF peptide mixture on IFN-γ ELISPOT plates. 
Plates were developed after 20 hours of culture, and the stimulation 
index (spots in the presence of CEF/spots in the absence of CEF) was 
calculated. (B) DCs (2 × 104) were cocultured with 1 × 105 tetanus toxin–
reactive HLA-DR–restricted SPF3 T cells in the presence or absence of 
25 μg/ml tetanus toxin. Cytokine release of T cells was determined after 
18–20 hours of coculture by ELISA. Culture of DCs or T cells alone did 
not lead to detectable cytokine production. One representative experi-
ment is shown. Two additional experiments with cells from independent 
ABL and control subjects showed comparable results.
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ABL PBMCs revealed no alterations beyond those related to CD1 
dysfunction (Supplemental Results).





































Proteasomal degradation leads to impaired group 1 CD1 expression in ABL. (A) Flow cytometric analysis of expression of the indicated 
molecules on DCs. For analysis of total (surface and intracellular) expression, cells were permeabilized before antibody staining. For surface 
staining, cells were stained and then fixed. Shown is the mean fluorescence intensity on a log10 scale. (B) Flow cytometric analysis of CD1 
and MHC class I expression after culture in the presence or absence of the indicated proteasomal inhibitors (10 μM) for 10 hours. Cells were 
permeabilized before antibody staining to allow for detection of total protein expression. Shown is the mean fluorescence intensity on a log10 
scale. One representative experiment is shown. One (B) and two (A) additional experiments with cells from independent ABL and control 
subjects showed comparable results.
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Restoration of CD1 expression and function in ABL upon MTP reconstitution. (A) Flow cytometric analysis of CD1 expression on ABL or control 
(CTR) DCs 3 days after infection with lentiviruses expressing MTP or the empty control virus. Shown is the mean fluorescence intensity on a log10 
scale. (B) Analysis of CD1-restricted presentation of self lipids 3 days after infection with lentiviruses expressing MTP or the empty control virus. 
DCs from healthy controls or ABL patients were cocultured with CD1-restricted T cells or iNKT cells. One representative experiment is shown. 
One additional experiment with cells from independent ABL and control subjects showed comparable results.
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Reduced iNKT levels and an altered iNKT phenotype in ABL. (A and B) iNKT levels in peripheral blood were determined by staining with 
αGalCer/CD1d tetramers or empty CD1d tetramers as control and are expressed as percentage of PBMCs. (C) Flow cytometric analysis of 
expression of cell surface markers on iNKT cells (upper panel) or conventional (tetramer-negative) T cells (lower panel) in peripheral blood. 
Shown is the mean fluorescence intensity. Dots represent individual subjects. Statistical significance was calculated using the 2-tailed Mann-
Whitney U test. Analysis of iNKT surface markers was limited to patients with detectable iNKT cells. Bars indicate the median.
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reduced  in ABL as  shown here,  the CD1 molecules  that pre-
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